Bladder Cancer Treatment: BCG vs. BCG/EMDA-MMC

We are studying two treatment methods for high-risk non-muscle-invasive bladder cancer to see which is more effective and safer. This trial will help us understand the best approach to prevent disease progression.

6-12 months Confirmation phase (III)No Placebo Standard MedicinesGynecology and ObstetricsInternal MedicineUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Bcg Medac

BCG Medac is a medicine used to treat early-stage bladder cancer by helping the body's immune system fight cancer cells in the bladder.

Mitomycin Medac

Mitomycin Medac is a chemotherapy medicine used to treat certain types of cancer by stopping tumor growth.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Bacillus Calmette-Guérin (Bcg)

Bacillus Calmette-Guérin (BCG) is a vaccine that helps protect against severe forms of tuberculosis, especially in young children.

Bcg (Bacillus Calmette-Guérin)

BCG is a live weakened bacterium used to prevent tuberculosis and to stimulate the immune system against bladder cancer.

Bcg (Bacillus Calmette-Guérin) Bacteria

BCG is a live weakened bacteria used to prevent tuberculosis and to stimulate immune response against certain bladder cancers.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Mitameta

Mitem

Mito-Extra

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Turku University Hospital

Urology

Turku, Finland

Sponsor: Turku University Hospital

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.